FilingReader Intelligence
Maccura Biotech gains new diagnostic product registration
July 22, 2025 at 05:26 AM UTC•By FilingReader AI
Maccura Biotechnology obtained a medical device registration certificate for its Mycoplasma pneumoniae IgG antibody detection kit, valid until July 2030.
The approval expands the company's diagnostic menu to 137 reagent products for its automated chemiluminescence immunoassay platforms.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Maccura Biotechnology publishes news
Free account required • Unsubscribe anytime